Back
ProShares Ultra MSCI Emerging Markets Vs. ProShares Ultra Health Care Industry Stock Comparison
Sell
48
EET
ProShares Ultra MSCI Emerging Markets
Last Price:
56.80
Seasonality Move:
7.73%
Sell
35
RXL
ProShares Ultra Health Care
Last Price:
102.00
Seasonality Move:
8.19%
Sell
48
ProShares Ultra MSCI Emerging Markets (EET)
is a Sell
Is ProShares Ultra MSCI Emerging Markets a Buy, Sell or Hold?
- The current ProShares Ultra MSCI Emerging Markets [EET] share price is $58.90. The Score for EET is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- EET is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
ProShares Ultra Health Care (RXL)
is a Sell
Is ProShares Ultra Health Care a Buy, Sell or Hold?
- The current ProShares Ultra Health Care [RXL] share price is $102.32. The Score for RXL is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- RXL is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EET Stock Price Chart
What is ProShares Ultra MSCI Emerging Markets's stock price today?
-
The ProShares Ultra MSCI Emerging Markets share price today is $58.90
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EET is experiencing buying pressure, which is a positive indicator for future bullish movement.
RXL Stock Price Chart
What is ProShares Ultra Health Care's stock price today?
-
The ProShares Ultra Health Care share price today is $102.32
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RXL is experiencing buying pressure, which is a positive indicator for future bullish movement.
EET Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.36 | Sell |
Relative Strength Index (14 RSI): | 50.9 | Buy |
Chaikin Money Flow: | 756 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (57.84 - 62.14) | Sell |
Bollinger Bands (100): | (52.8 - 59.66) | Buy |
RXL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.43 | Sell |
Relative Strength Index (14 RSI): | 36.25 | Sell |
Chaikin Money Flow: | 899 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (103.48 - 110.42) | Sell |
Bollinger Bands (100): | (102.97 - 112.63) | Sell |
EET Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 57.9 | Buy |
20-day SMA: | 59.16 | Sell |
50-day SMA: | 57.86 | Buy |
200-day SMA: | 53.76 | Buy |
8-day EMA: | 58.06 | Buy |
20-day EMA: | 58.7 | Buy |
50-day EMA: | 58.06 | Buy |
200-day EMA: | 54.55 | Buy |
RXL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 102.54 | Sell |
20-day SMA: | 106.56 | Sell |
50-day SMA: | 110.21 | Sell |
200-day SMA: | 103.9 | Sell |
8-day EMA: | 102.9 | Sell |
20-day EMA: | 105.46 | Sell |
50-day EMA: | 107.75 | Sell |
200-day EMA: | 103.49 | Sell |
ProShares Ultra MSCI Emerging Markets Earnings Growth & EET Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ProShares Ultra Health Care Earnings Growth & RXL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ProShares Ultra MSCI Emerging Markets Technical Analysis
Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
ProShares Ultra Health Care Technical Analysis
Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |